FRC's Tony Perkins Applauds Louisiana's Lawsuit Against FDA Over the Abortion Pill

BATON, ROUGE, LA -- On Monday, the state of Louisiana filed a lawsuit against the Food and Drug Administration challenging the conditions under which the abortion drug mifepristone may be sold within Louisiana and the rest of the United States. The lawsuit notes that "from April to June 2024 alone, mail-order abortion drugs--sent into Louisiana from doctors and activists in other states--accounted for an average of 617 abortions in Louisiana per month." The lawsuit asks the U.S. District Court for the Western District of Louisiana to re-instate the pre-2023 Risk Evaluation and Mitigation Strategy (REMS) on the abortion drug, once again require in-person dispensing and prohibit mail-order pharmacies from dispensing mifepristone, preventing the interstate mailing of it.

Family Research Council President Tony Perkins, a former Louisiana state legislator, commented on the lawsuit:

"Mifepristone has become a murder weapon. The drug is under review because it is unsafe for women--but it is also a tool used by killers--many times against a woman's will or without her knowledge. While a transparent, unbiased review of mifepristone is taking place, abusers could be disarmed if the Trump administration would re-enact and strengthen the FDA safety protocols originally governing the drug. I applaud my home state of Louisiana for filing this lawsuit to reinstate commonsense safety requirements that the Biden administration so callously and dangerously removed. The Trump administration should repeal approval of mifepristone altogether, but it should also swiftly adopt a policy that aligns with its declaration that abortion belongs under state jurisdiction," Perkins concluded.

Louisiana Attorney General Liz Murrill will appear on "Washington Watch with Tony Perkins" tonight at 5:30 PM ET to discuss the lawsuit. The live broadcast is available at tonyperkins.com.

-30-